Autor: "Rappa, Alessandra" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients.
Autorzy :: Fumagalli C; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Department of Diagnostic Services, Division of Pathology, Azienda Socio Sanitaria Territoriale (ASST) Valle Olona, 21013 Gallarate, Italy.
Betella I; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
Rappa A; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
di Giminiani M; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Department of Health Sciences, University of Milan, 20122 Milan, Italy.
Gaiano M; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Obstetrics and Gynaecology Unit, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
De Vitis LA; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Department of Health Sciences, University of Milan, 20122 Milan, Italy.
Zambetti B; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Obstetrics and Gynaecology Unit, Department of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy.
Vacirca D; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
Multinu F; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
Venetis K; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
Colombo N; Division of Gynecologic Oncology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; School of Medicine and Surgery, Università degli Studi di Milano-Bicocca, 20126 Milan, Italy.
Barberis M; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
Guerini Rocco E; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2022 Mar 23; Vol. 14 (7). Date of Electronic Publication: 2022 Mar 23.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 2 2.

Tytuł :: Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.
Autorzy :: Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
Porta FM; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; School of Pathology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
Rappa A; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Guerini-Rocco E; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Viale G; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Barberis M; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
de Marinis F; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
Catania C; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Pokaż więcej
Źródło :: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Aug 31; Vol. 28 (5), pp. 3384-3392. Date of Electronic Publication: 2021 Aug 31.
Typ publikacji :: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Adenocarcinoma of Lung*/diagnosis
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Breast Neoplasms*/diagnosis
Breast Neoplasms*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Diagnosis, Differential ; ErbB Receptors/genetics ; Female ; Humans ; Mutation
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Microsatellite instability evaluation: which test to use for endometrial cancer?
Autorzy :: Rafaniello-Raviele P; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.
Betella I; Department of Gynecologic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.
Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.
Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.
Tolva G; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.
Guerrieri-Gonzaga A; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.
Bertario L; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.
Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy .
Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.
Marabelli M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy.; Pokaż więcej
Źródło :: Journal of clinical pathology [J Clin Pathol] 2021 Jul 26. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Author Correction: A role for the immune system in advanced laryngeal cancer.
Autorzy :: Tagliabue M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy. .
Maffini F; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Fumagalli C; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Gandini S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
Lepanto D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Corso F; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
Cacciola S; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Ranghiero A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Cossu Rocca M; Department of Medical Oncology, Urogenital and Head and Neck Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Alterio D; Division of Radiotherapy, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Guerini Rocco E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy.
Cattaneo A; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Chu F; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Zorzi S; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Curigliano G; Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Chiocca S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy.
Ansarin M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Pokaż więcej
Źródło :: Scientific reports [Sci Rep] 2021 May 03; Vol. 11 (1), pp. 9760. Date of Electronic Publication: 2021 May 03.
Typ publikacji :: Published Erratum

Szczegóły Pełny tekst

Skocz do pozycji: 5 5.

Tytuł :: Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations.
Autorzy :: Passaro A; Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Attili I; Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Rappa A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Vacirca D; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Ranghiero A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Fumagalli C; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Guarize J; Department of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Spaggiari L; Department of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
de Marinis F; Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Barberis M; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Guerini-Rocco E; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2021 Apr 30; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 30.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 6 6.

Tytuł :: SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma.
Autorzy :: Guerini-Rocco E; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.
Taormina SV; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Vacirca D; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Ranghiero A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Rappa A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Fumagalli C; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Maffini F; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Rampinelli C; Division of Radiology, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Galetta D; Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Tagliabue M; Division of Otolaryngology and Head-Neck Surgery, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Ansarin M; Division of Otolaryngology and Head-Neck Surgery, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Barberis M; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milano, Italy .; Pokaż więcej
Źródło :: Journal of clinical pathology [J Clin Pathol] 2020 Nov; Vol. 73 (11), pp. 754-757. Date of Electronic Publication: 2020 May 04.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Betacoronavirus/*isolation & purification
Carcinoma, Squamous Cell/*surgery
Clinical Laboratory Techniques/*methods
Coronavirus Infections/*diagnosis
Pneumonia, Viral/*diagnosis
Postoperative Complications/*diagnosis
Tissue Preservation/*methods
Tongue Neoplasms/*surgery
Betacoronavirus/genetics ; COVID-19 ; COVID-19 Testing ; Carcinoma, Squamous Cell/complications ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/virology ; Coronavirus Infections/etiology ; Coronavirus Infections/virology ; Fixatives ; Formaldehyde ; Humans ; Male ; Middle Aged ; Pandemics ; Paraffin Embedding ; Pneumonia, Viral/etiology ; Pneumonia, Viral/virology ; Postoperative Complications/virology ; RNA, Viral/analysis ; RNA, Viral/isolation & purification ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2 ; Tissue Fixation/methods ; Tongue Neoplasms/complications ; Tongue Neoplasms/pathology ; Tongue Neoplasms/virology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: A role for the immune system in advanced laryngeal cancer.
Autorzy :: Tagliabue M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy. .
Maffini F; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Fumagalli C; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Gandini S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
Lepanto D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Corso F; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
Cacciola S; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Ranghiero A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Cossu Rocca M; Department of Medical Oncology, Urogenital and Head and Neck Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Alterio D; Division of Radiotherapy, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Guerini Rocco E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, School of Medicine, State University of Milan, Milan, Italy.
Cattaneo A; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Chu F; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Zorzi S; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Curigliano G; Department of Oncology and Hemato-Oncology, School of Medicine, State University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Chiocca S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, School of Medicine, State University of Milan, Milan, Italy.
Ansarin M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Pokaż więcej
Źródło :: Scientific reports [Sci Rep] 2020 Oct 27; Vol. 10 (1), pp. 18327. Date of Electronic Publication: 2020 Oct 27.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Laryngeal Neoplasms/*immunology
Aged ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Immunity/genetics ; Immunity/immunology ; Laryngeal Neoplasms/diagnosis ; Laryngeal Neoplasms/pathology ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/metabolism ; Prognosis ; Retrospective Studies ; Sequence Analysis, RNA
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 8 8.

Tytuł :: Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
Autorzy :: Fumagalli C; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Ranghiero A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Gandini S; Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Corso F; Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Taormina S; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
De Camilli E; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Rappa A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Vacirca D; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Viale G; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Guerini-Rocco E; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy. .; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. .
Barberis M; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.; Pokaż więcej
Źródło :: Breast cancer research : BCR [Breast Cancer Res] 2020 Oct 15; Vol. 22 (1), pp. 107. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Mutation*
Biomarkers, Tumor/*genetics
Breast Neoplasms/*genetics
Genomics/*methods
Molecular Targeted Therapy/*methods
Neoplasm Recurrence, Local/*genetics
Adult ; Aged ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Class I Phosphatidylinositol 3-Kinases/genetics ; Drug Resistance, Neoplasm ; Female ; High-Throughput Nucleotide Sequencing/methods ; Humans ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Neoplasm Staging ; Prognosis ; Proto-Oncogene Proteins c-myc/genetics ; Survival Rate ; Tumor Suppressor Protein p53/genetics ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Comprehensive Genomic Analysis Reveals the Prognostic Role of LRRK2 Copy-Number Variations in Human Malignancies.
Autorzy :: Lopez G; Pathology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.; School of Pathology, University of Milan, 20122 Milan, Italy.
Lazzeri G; Neurology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.; School of Neurology, University of Milan, 20122 Milan, Italy.
Rappa A; European Institute of Oncology (IEO), 20141 Milan, Italy.
Isimbaldi G; Unit of Surgical Pathology and Cytogenetics, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.
Cribiù FM; Pathology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Guerini-Rocco E; European Institute of Oncology (IEO), 20141 Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, 20122 Milan, Italy.
Ferrero S; Pathology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Department of Biomedical, Surgical, and Dental Sciences, University of Milan, 20122 Milan, Italy.
Vaira V; Pathology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Di Fonzo A; Neurology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, 20122 Milan, Italy.; Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.; Pokaż więcej
Źródło :: Genes [Genes (Basel)] 2020 Jul 24; Vol. 11 (8). Date of Electronic Publication: 2020 Jul 24.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: DNA Copy Number Variations*
Genomics/*methods
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/*genetics
Neoplasms/*genetics
Neoplasms/*pathology
Genetic Testing ; Humans ; Prognosis ; Survival Rate
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Next-generation sequencing-based BRCA testing on cytological specimens from ovarian cancer ascites reveals high concordance with tumour tissue analysis.
Autorzy :: Fumagalli C; Division of Pathology, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Rappa A; Division of Pathology, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Casadio C; Division of Pathology, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Betella I; Division of Gynecologic Surgery, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
Colombo N; Division of Gynecologic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; School of Medicine and Surgery, Università degli Studi di Milano-Bicocca, Milan, Italy.
Barberis M; Division of Pathology, IEO, European Institute of Oncology, IRCCS, Milano, Italy .
Guerini-Rocco E; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Pokaż więcej
Źródło :: Journal of clinical pathology [J Clin Pathol] 2020 Mar; Vol. 73 (3), pp. 168-171. Date of Electronic Publication: 2019 Sep 19.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: High-Throughput Nucleotide Sequencing*
Ascites/*genetics
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Biomarkers, Tumor/*genetics
DNA Mutational Analysis/*methods
Ovarian Neoplasms/*genetics
Ascites/pathology ; Clinical Decision-Making ; Feasibility Studies ; Female ; Genetic Predisposition to Disease ; Humans ; Mutation ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Patient Selection ; Phenotype ; Phthalazines/therapeutic use ; Piperazines/therapeutic use ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Predictive Value of Tests
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy.
Autorzy :: Fumagalli C; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. .
Tomao F; Department of Obstetric, Gynecologic and Urologic Sciences, University of Rome 'Sapienza', 00161 Rome, Italy. .
Betella I; Division of Gynecologic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
Rappa A; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. alessandra.rappa@ieo.it.
Calvello M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
Bernard L; Clinical Genomics Lab, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
Peccatori F; Division of Gynecologic Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
Colombo N; Division of Gynecologic Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .; School of Medicine and Surgery, Università degli Studi di Milano-Bicocca, 20126 Milan, Italy. .
Viale G; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. .; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy. .
Barberis M; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. .
Guerini-Rocco E; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. .; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy. .; Pokaż więcej
Źródło :: Cancers [Cancers (Basel)] 2019 Oct 24; Vol. 11 (11). Date of Electronic Publication: 2019 Oct 24.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 12 12.

Tytuł :: A case of Warthin-like papillary thyroid carcinoma with diffuse sclerosing stroma and a novel RET mutation: a new entity or a combined tumour?
Autorzy :: Maffini F; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.; These authors contributed equally to writing this article.
Lorenzini D; University of Milan School of Medicine, Via Ripamonti 435, 20141 Milan, Italy.; These authors contributed equally to writing this article.
Lepanto D; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
De Fiori E; Department of Radiology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
Fumagalli C; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
Rappa A; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
Tagliabue M; Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
Barberis M; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.; Pokaż więcej
Źródło :: Ecancermedicalscience [Ecancermedicalscience] 2019 Oct 02; Vol. 13, pp. 965. Date of Electronic Publication: 2019 Oct 02 (Print Publication: 2019).
Typ publikacji :: Case Reports
: Raport

Szczegóły Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.
Autorzy :: Pisapia P; Department of Public Health, University of Naples Federico II, Naples, Italy.
Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Roma G; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
Saddar S; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
Zheng Q; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
Pepe F; Department of Public Health, University of Naples Federico II, Naples, Italy.
Bruzzese D; Department of Public Health, University of Naples Federico II, Naples, Italy.
Vigliar E; Department of Public Health, University of Naples Federico II, Naples, Italy.
Bellevicine C; Department of Public Health, University of Naples Federico II, Naples, Italy.
Luthra R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Nikiforov YE; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Mayo-de-Las-Casas C; Laboratory of Oncology, Pangaea Oncology, Barcelona, Spain.
Molina-Vila MA; Laboratory of Oncology, Pangaea Oncology, Barcelona, Spain.
Rosell R; Catalan Institute of Oncology, Badalona, Spain.; Rosell Cancer Institute, Quiròn-Dexeus University Institute, Barcelona, Spain.
Bihl M; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Savic S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Bubendorf L; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
de Biase D; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Tallini G; Anatomic Pathology, University of Bologna Medical Center, Bologna, Italy.
Hwang DH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Vander Borght S; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
Weynand B; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
Stieber D; National Health Laboratory, Dudelange, Luxembourg.
Vielh P; National Health Laboratory, Dudelange, Luxembourg.
Rappa A; Division of Pathology, European Institute of Oncology, Milan, Italy.
Barberis M; Division of Pathology, European Institute of Oncology, Milan, Italy.
Fassan M; Surgical Pathology Unit, Department of Medicine, University of Padua, Padua, Italy.
Rugge M; Surgical Pathology Unit, Department of Medicine, University of Padua, Padua, Italy.
De Andrea CE; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
Lozano MD; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
Lupi C; Department of Surgical, Medical, and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Fontanini G; Department of Surgical, Medical, and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Schmitt F; Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.; Department of Pathology, Medical Faculty, Porto University, Porto, Portugal.
Dumur CI; Department of Pathology, Virginia Commonwealth University, Richmond, Virginia.
Bisig B; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Bongiovanni M; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Merkelbach-Bruse S; Institute of Pathology and Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Büttner R; Institute of Pathology and Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Nikiforova MN; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Troncone G; Department of Public Health, University of Naples Federico II, Naples, Italy.; Pokaż więcej
Corporate Authors :: Molecular Cytopathology Meeting Group
Źródło :: Cancer cytopathology [Cancer Cytopathol] 2019 May; Vol. 127 (5), pp. 285-296. Date of Electronic Publication: 2019 Apr 25.
Typ publikacji :: Journal Article
MeSH Terms :: Mutation*
Biomarkers, Tumor/*genetics
Cytodiagnosis/*methods
DNA Mutational Analysis/*methods
High-Throughput Nucleotide Sequencing/*methods
Neoplasms/*diagnosis
ErbB Receptors/genetics ; Humans ; Neoplasms/genetics ; Proto-Oncogene Mas ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Reproducibility of Results
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
Autorzy :: Fumagalli C; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
Vacirca D; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
Rappa A; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
Passaro A; Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.
Guarize J; Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy.
Rafaniello Raviele P; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
de Marinis F; Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.
Spaggiari L; Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Casadio C; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
Viale G; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Barberis M; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
Guerini-Rocco E; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Pokaż więcej
Źródło :: Journal of clinical pathology [J Clin Pathol] 2018 Sep; Vol. 71 (9), pp. 767-773. Date of Electronic Publication: 2018 Mar 13.
Typ publikacji :: Evaluation Study; Journal Article
MeSH Terms :: High-Throughput Nucleotide Sequencing*
Mutation*
Transcriptome*
Biomarkers, Tumor/*genetics
Carcinoma, Non-Small-Cell Lung/*genetics
DNA Mutational Analysis/*methods
Gene Expression Profiling/*methods
Lung Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/therapy ; Feasibility Studies ; Female ; Gene Rearrangement ; Genetic Predisposition to Disease ; Humans ; In Situ Hybridization, Fluorescence ; Italy ; Lung Neoplasms/pathology ; Lung Neoplasms/therapy ; Male ; Middle Aged ; Phenotype ; Predictive Value of Tests ; Prognosis ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
Autorzy :: De Luca C; Department of Public Health, University of Naples Federico II, Naples, Italy.
Rappa AG; Division of Pathology and Laboratory Medicine, Istituto Europeo di Oncologia, Milan, Italy.
Gragnano G; Department of Public Health, University of Naples Federico II, Naples, Italy.
Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Troncone G; Department of Public Health, University of Naples Federico II, Naples, Italy.
Barberis M; Division of Pathology and Laboratory Medicine, Istituto Europeo di Oncologia, Milan, Italy.; Pokaż więcej
Źródło :: Journal of clinical pathology [J Clin Pathol] 2018 Aug; Vol. 71 (8), pp. 745-750. Date of Electronic Publication: 2018 May 24.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Algorithms*
High-Throughput Nucleotide Sequencing*/instrumentation
Mutation*
Biomarkers, Tumor/*genetics
Carcinoma, Non-Small-Cell Lung/*genetics
DNA Mutational Analysis/*methods
ErbB Receptors/*genetics
Lung Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Automation, Laboratory ; Carcinoma, Non-Small-Cell Lung/pathology ; DNA Mutational Analysis/instrumentation ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Predictive Value of Tests ; Real-Time Polymerase Chain Reaction ; Reproducibility of Results ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
Autorzy :: Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Mayo-de-Las-Casas C; Laboratory of Oncology, Pangaea Biotech, Barcelona, Spain.
Molina-Vila MA; Laboratory of Oncology, Pangaea Biotech, Barcelona, Spain.
Rosell R; Catalan Institute of Oncology, Badalona, Spain.; Instituto Oncológico Dr Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain.
Savic S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Bihl M; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Bubendorf L; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
Salto-Tellez M; Molecular Pathology Programme, Centre for Cancer Research and Cell Biology Queen's University Belfast, Belfast, United Kingdom.
de Biase D; Department of Pharmacy and Biotechnology - University of Bologna, Bologna, Italy.
Tallini G; Department of Medicine University of Bologna, Bologna, Italy.
Hwang DH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Luthra R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Weynand B; Department of Pathology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
Vander Borght S; Department of Pathology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
Missiaglia E; Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Bongiovanni M; Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Stieber D; National Health Laboratory, Dudelange, Luxembourg.
Vielh P; National Health Laboratory, Dudelange, Luxembourg.
Schmitt F; National Health Laboratory, Dudelange, Luxembourg.
Rappa A; Division of Pathology, European Institute of Oncology, Milan, Italy.
Barberis M; Division of Pathology, European Institute of Oncology, Milan, Italy.
Pepe F; Department of Public Health, University of Naples Federico II, Naples, Italy.
Pisapia P; Department of Public Health, University of Naples Federico II, Naples, Italy.
Serra N; Department of Public Health, University of Naples Federico II, Naples, Italy.
Vigliar E; Department of Public Health, University of Naples Federico II, Naples, Italy.
Bellevicine C; Department of Public Health, University of Naples Federico II, Naples, Italy.
Fassan M; Department of Medicine (DIMED), Surgical Pathology Unit University of Padua, Padua, Italy.
Rugge M; Department of Medicine (DIMED), Surgical Pathology Unit University of Padua, Padua, Italy.
de Andrea CE; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
Lozano MD; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
Basolo F; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Fontanini G; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Nikiforov YE; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Kamel-Reid S; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
da Cunha Santos G; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
Nikiforova MN; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Roy-Chowdhuri S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Troncone G; Department of Public Health, University of Naples Federico II, Naples, Italy.; Pokaż więcej
Corporate Authors :: Molecular Cytopathology Meeting Group
Źródło :: Cancer cytopathology [Cancer Cytopathol] 2017 Aug; Vol. 125 (8), pp. 615-626. Date of Electronic Publication: 2017 May 05.
Typ publikacji :: Journal Article
MeSH Terms :: Colonic Neoplasms/*genetics
DNA Mutational Analysis/*methods
High-Throughput Nucleotide Sequencing/*methods
Sequence Analysis, DNA/*methods
Cell Line ; Cell Line, Tumor ; Class I Phosphatidylinositol 3-Kinases ; ErbB Receptors/genetics ; GTP Phosphohydrolases/genetics ; Gene Frequency ; Humans ; Membrane Proteins/genetics ; Phosphatidylinositol 3-Kinases/genetics ; Proto-Oncogene Mas ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Real-Time Polymerase Chain Reaction ; Reproducibility of Results
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment.
Autorzy :: Passaro A; Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy. Electronic address: .
Guerini-Rocco E; Clinic Unit of Histopathology and Molecular Diagnostics, Division of Pathology, European Institute of Oncology, Milan, Italy.
Pochesci A; Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.
Vacirca D; Clinic Unit of Histopathology and Molecular Diagnostics, Division of Pathology, European Institute of Oncology, Milan, Italy.
Spitaleri G; Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.
Catania CM; Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.
Rappa A; Clinic Unit of Histopathology and Molecular Diagnostics, Division of Pathology, European Institute of Oncology, Milan, Italy.
Barberis M; Clinic Unit of Histopathology and Molecular Diagnostics, Division of Pathology, European Institute of Oncology, Milan, Italy.
de Marinis F; Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.; Pokaż więcej
Źródło :: Pharmacological research [Pharmacol Res] 2017 Mar; Vol. 117, pp. 406-415. Date of Electronic Publication: 2017 Jan 12.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antineoplastic Agents/*pharmacology
Antineoplastic Agents/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
ErbB Receptors/*genetics
Lung Neoplasms/*drug therapy
Mutation/*drug effects
Animals ; Carcinoma, Non-Small-Cell Lung/genetics ; Disease-Free Survival ; Humans ; Lung Neoplasms/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Arachidonic acid-evoked Ca signals promote nitric oxide release and proliferation in human endothelial colony forming cells.
Autorzy :: Zuccolo E; Laboratory of General Physiology, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy.
Dragoni S; Department of Cell Biology, Institute of Ophthalmology, University College London, 11-43 Bath Street, EC1V 9EL London, United Kingdom.
Poletto V; Center for the Study of Myelofibrosis, Biotechnology Research Laboratory, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Catarsi P; Center for the Study of Myelofibrosis, Biotechnology Research Laboratory, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Guido D; Laboratory of General Physiology, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy.
Rappa A; Laboratory of General Physiology, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy.
Reforgiato M; Laboratory of General Physiology, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy.
Lodola F; Laboratory of General Physiology, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy.
Lim D; Department of Pharmaceutical Sciences, Università del Piemonte Orientale 'Amedeo Avogadro', 28100 Novara, Italy.
Rosti V; Center for the Study of Myelofibrosis, Biotechnology Research Laboratory, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Guerra G; Department of Medicine and Health Sciences 'Vincenzo Tiberio', University of Molise, 86100 Campobasso, Italy.
Moccia F; Department of Cell Biology, Institute of Ophthalmology, University College London, 11-43 Bath Street, EC1V 9EL London, United Kingdom. Electronic address: .; Pokaż więcej
Źródło :: Vascular pharmacology [Vascul Pharmacol] 2016 Dec; Vol. 87, pp. 159-171. Date of Electronic Publication: 2016 Sep 12.
Typ publikacji :: Journal Article
MeSH Terms :: Arachidonic Acid/*metabolism
Calcium/*metabolism
Endothelial Progenitor Cells/*metabolism
Nitric Oxide/*metabolism
Adult ; Arachidonic Acid/administration & dosage ; Calcium Signaling/drug effects ; Cell Proliferation/drug effects ; Cells, Cultured ; Dose-Response Relationship, Drug ; Endoplasmic Reticulum/metabolism ; Humans ; NG-Nitroarginine Methyl Ester/pharmacology ; Nitric Oxide Synthase Type III/metabolism ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: A functional transient receptor potential vanilloid 4 (TRPV4) channel is expressed in human endothelial progenitor cells.
Autorzy :: Dragoni S; Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Guerra G
Fiorio Pla A
Bertoni G
Rappa A
Poletto V
Bottino C
Aronica A
Lodola F
Cinelli MP
Laforenza U
Rosti V
Tanzi F
Munaron L
Moccia F; Pokaż więcej
Źródło :: Journal of cellular physiology [J Cell Physiol] 2015 Jan; Vol. 230 (1), pp. 95-104.
Typ publikacji :: Journal Article
MeSH Terms :: Endothelial Cells/*metabolism
Endothelium, Vascular/*metabolism
Neovascularization, Physiologic/*physiology
Stem Cells/*metabolism
TRPV Cation Channels/*biosynthesis
Adult ; Anilides/pharmacology ; Calcium/metabolism ; Cation Transport Proteins/biosynthesis ; Cell Proliferation/drug effects ; Cells, Cultured ; Endothelial Cells/cytology ; Humans ; Leucine/analogs & derivatives ; Leucine/pharmacology ; RNA, Messenger/biosynthesis ; Ruthenium Red/pharmacology ; Stem Cells/cytology ; Sulfonamides/pharmacology ; TRPV Cation Channels/agonists ; TRPV Cation Channels/antagonists & inhibitors ; TRPV Cation Channels/genetics ; Tetradecanoylphorbol Acetate/pharmacology ; Thiadiazoles/pharmacology ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Enhanced expression of Stim, Orai, and TRPC transcripts and proteins in endothelial progenitor cells isolated from patients with primary myelofibrosis.
Autorzy :: Dragoni S; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Laforenza U; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Bonetti E; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
Reforgiato M; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Poletto V; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
Lodola F; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Bottino C; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Guido D; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Rappa A; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Pareek S; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Tomasello M; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Guarrera MR; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Cinelli MP; Department of Public Health, University of Naples 'Federico II', Naples, Italy.
Aronica A; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
Guerra G; Department of Health Sciences, University of Molise, Campobasso, Italy.
Barosi G; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
Tanzi F; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
Rosti V; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
Moccia F; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2014 Mar 06; Vol. 9 (3), pp. e91099. Date of Electronic Publication: 2014 Mar 06 (Print Publication: 2014).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Calcium Channels/*metabolism
Endothelial Progenitor Cells/*metabolism
Membrane Proteins/*metabolism
Primary Myelofibrosis/*genetics
Primary Myelofibrosis/*pathology
TRPC Cation Channels/*metabolism
Adenosine Triphosphate/pharmacology ; Adult ; Aged ; Anilides/pharmacology ; Calcium/metabolism ; Calcium Channels/genetics ; Cell Proliferation/drug effects ; Cell Separation ; Colony-Forming Units Assay ; Endoplasmic Reticulum/drug effects ; Endoplasmic Reticulum/metabolism ; Endothelial Progenitor Cells/drug effects ; Female ; Gadolinium/pharmacology ; Humans ; Indoles/pharmacology ; Inositol 1,4,5-Trisphosphate/metabolism ; Intracellular Space/drug effects ; Intracellular Space/metabolism ; Lanthanum/pharmacology ; Male ; Membrane Potentials/drug effects ; Membrane Proteins/genetics ; Middle Aged ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Signal Transduction/drug effects ; TRPC Cation Channels/genetics ; Thiadiazoles/pharmacology ; Young Adult
: Czasopismo naukowe

Szczegóły Pełny tekst

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Rappa, Alessandra"" wg kryterium: Autor

Aktywne filtry:

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język